drugset / Trial / NCT01929629

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914

NCT01929629

Phase 1 Completed 100 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to assess the safety and tolerability of orally administered AZD0914 in healthy adult subjects.

Timeline

Start
2013-09
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Zoliflodacin Small molecule Oral

Indications